Bridion Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Bridion
E
- EContra EZ (levonorgestrel)
- EContra One-Step (levonorgestrel)
- edoxaban
- elagolix / estradiol / norethindrone
- Elifemme (ethinyl estradiol / levonorgestrel)
- Elinest (ethinyl estradiol / norgestrel)
- Eliquis (apixaban)
- EluRyng (ethinyl estradiol / etonogestrel)
- Emoquette (desogestrel / ethinyl estradiol)
- Emzahh (norethindrone)
- Ena (estradiol / norethindrone)
- EnilloRing (ethinyl estradiol / etonogestrel)
- enoxaparin
- Enpresse (ethinyl estradiol / levonorgestrel)
- Enskyce (desogestrel / ethinyl estradiol)
- Errin (norethindrone)
- Estarylla (ethinyl estradiol / norgestimate)
- estradiol / levonorgestrel
- estradiol / medroxyprogesterone
- estradiol / norethindrone
- estradiol / norethindrone / relugolix
- estradiol / norgestimate
- Estrostep Fe (ethinyl estradiol / norethindrone)
- ethinyl estradiol / ethynodiol
- ethinyl estradiol / etonogestrel
- ethinyl estradiol / folic acid / levonorgestrel
- ethinyl estradiol / levonorgestrel
- ethinyl estradiol / norelgestromin
- ethinyl estradiol / norethindrone
- ethinyl estradiol / norgestimate
- ethinyl estradiol / norgestrel
- ethinyl estradiol / segesterone
- etonogestrel
- Etyqa (estradiol / norethindrone)
More about Bridion (sugammadex)
- Bridion consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.